When a problem puts millions of lives at risk, costs economies billions of dollars and undermines decades of hard-earned health progress, it deserves prompt and strategic attention. I’m describing the consequences of poor-quality medicines – a worldwide problem that deserves worldwide attention.
As personalized therapies have become a reality rather than a distant promise, the tools needed to ensure the quality of these medicines grow increasingly important.
As government agencies consider solutions to the growing opioid crisis, the Food and Drug Administration (FDA) recently sought public comment about ways to best address this national emergency.
Dr. Wesley (Wes) Workman, USP Volunteer and Chair, General Chapters–Biological Analysis Expert Committee reflects on his volunteer role at USP and his work with what he refers to as the "dream team" of the heparin world.
Today, we join the global health community in marking World Malaria Day. As we reflect on the major strides being made against this deadly disease, we also recognize that critical obstacles remain.
An appreciation of science, scientists, and the questions they ask. Read more.
TB kills more people than any other single infectious disease. Learn how PQM – a public health program supported by USAID & implemented by USP - is helping to increase the global supply of quality-assured kanamycin, an essential TB drug.
Show 11 More